219 related articles for article (PubMed ID: 26444734)
1. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Cannon CP; Blazing MA; Braunwald E
N Engl J Med; 2015 Oct; 373(15):1476-7. PubMed ID: 26444734
[No Abstract] [Full Text] [Related]
2. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Singh JS; Struthers AD; Lang CC
N Engl J Med; 2015 Oct; 373(15):1476. PubMed ID: 26444741
[No Abstract] [Full Text] [Related]
3. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Richard T; Lelubre C; Vanhaeverbeek M
N Engl J Med; 2015 Oct; 373(15):1475-6. PubMed ID: 26444740
[No Abstract] [Full Text] [Related]
4. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Nunes JP
N Engl J Med; 2015 Oct; 373(15):1475. PubMed ID: 26444739
[No Abstract] [Full Text] [Related]
5. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Patti G; Cavallari I
N Engl J Med; 2015 Oct; 373(15):1474-5. PubMed ID: 26444738
[No Abstract] [Full Text] [Related]
6. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Egom EE
N Engl J Med; 2015 Oct; 373(15):1474. PubMed ID: 26444737
[No Abstract] [Full Text] [Related]
7. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Couture P; Durand M; Laskine M
N Engl J Med; 2015 Oct; 373(15):1473-4. PubMed ID: 26444736
[No Abstract] [Full Text] [Related]
8. Ezetimibe plus a Statin after Acute Coronary Syndromes.
Silbernagel G; Baumgartner I; März W
N Engl J Med; 2015 Oct; 373(15):1473. PubMed ID: 26444735
[No Abstract] [Full Text] [Related]
9. Ezetimibe-Statin Combination to Reduce Cardiovascular Events: The Evidence Base.
Jialal I; Abate N
Metab Syndr Relat Disord; 2015 Oct; 13(8):327-8. PubMed ID: 26177147
[No Abstract] [Full Text] [Related]
10. [Role of ezetimibe in secondary cardiovascular prevention finally determined?].
Lanzi D; Fumeaux T
Rev Med Suisse; 2015 Nov; 11(496):2257. PubMed ID: 26742360
[No Abstract] [Full Text] [Related]
11. Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome.
Toth PP
Evid Based Med; 2015 Oct; 20(5):176. PubMed ID: 26261287
[No Abstract] [Full Text] [Related]
12. Dyslipidaemia: No limit to the benefits of LDL-cholesterol lowering.
Lim GB
Nat Rev Cardiol; 2015 Aug; 12(8):444. PubMed ID: 26099842
[No Abstract] [Full Text] [Related]
13. Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT.
Jarcho JA; Keaney JF
N Engl J Med; 2015 Jun; 372(25):2448-50. PubMed ID: 26039520
[No Abstract] [Full Text] [Related]
14. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP; Blazing MA; Giugliano RP; McCagg A; White JA; Theroux P; Darius H; Lewis BS; Ophuis TO; Jukema JW; De Ferrari GM; Ruzyllo W; De Lucca P; Im K; Bohula EA; Reist C; Wiviott SD; Tershakovec AM; Musliner TA; Braunwald E; Califf RM;
N Engl J Med; 2015 Jun; 372(25):2387-97. PubMed ID: 26039521
[TBL] [Abstract][Full Text] [Related]
15. Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
Blazing MA; Giugliano RP; Cannon CP; Musliner TA; Tershakovec AM; White JA; Reist C; McCagg A; Braunwald E; Califf RM
Am Heart J; 2014 Aug; 168(2):205-12.e1. PubMed ID: 25066560
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein lowering therapy: an analysis of the options.
Sacks FM
J Am Coll Cardiol; 2002 Dec; 40(12):2135-8. PubMed ID: 12505225
[No Abstract] [Full Text] [Related]
17. [On the current debate on lowering LDL cholesterol with ezetimibe].
Breuer HW
Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
[No Abstract] [Full Text] [Related]
18. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering study raises issues of therapy's value.
Thompson CA
Am J Health Syst Pharm; 2008 Apr; 65(7):594-5. PubMed ID: 18359962
[No Abstract] [Full Text] [Related]
20. Ezetimibe plus simvastatin cardiovascular outcomes study program.
Padial LR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]